Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
Exxon Labels Venezuela 'Uninvestable' Without Major Reforms
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
United States: TotalEnergies Pursues its Gas Value Chain Integration by Acquiring Producing Assets in the Anadarko Basin
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
Market Is Following a Classic January Playbook So Far
Permian Oil Drilling Rig Count Rises in 6 of Prior 10 Weeks
Continental (CLR) Stock Up Marginally Despite Q3 Earnings Miss
Continental Resources (CLR) Q3 Earnings and Revenues Lag Estimates
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, USER, CLR
Why Continental Resources (CLR) Could Beat Earnings Estimates Again
Continental Resources (CLR) Moves 8.7% Higher: Will This Strength Last?
Permian Oil Drilling Rig Count Rises for Two Straight Weeks
Continental Resources Acquisition Faces Pushback
Oil tycoon Harold Hamm to acquire Continental Resources for $74.28 per share
Continental Resources (CLR) Stock Jumps on Buyout Offer
Continental Resources Stock Surges On Boosted Takeover Offer
Continental Resources stock jumps after agreeing to be bought by founder in deal valuing company at $27 billion
Continental Resources Is A Strong Pure-Play Oil Stock
Here's Why Continental Resources (CLR) is a Strong Value Stock